 |
138 Diseases |  |
93 Trials |
|
93 Trials |  |
2194 News |  |
| «12...22232425262728293031323334» |
- | Xtandi (enzalutamide capsule) / Pfizer, Astellas
Enrollment open: Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer (clinicaltrials.gov) - May 12, 2014
P2, N=15, Recruiting, Sponsor: University of Texas Southwestern Medical Center
Not yet recruiting --> Recruiting
- ||| leuprorelin depot / Generic mfg.
Clinical: Leuprorelin Acetate SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients" (clinicaltrials.gov) - May 7, 2014
P=N/A, N=2816, Active, not recruiting, Sponsor: Takeda
- |||| Orgovyx (relugolix) / Intas, Gedeon Richter, Takeda, ASKA Pharma, Sumitomo Pharma, Pfizer
Trial completion: A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis (clinicaltrials.gov) - May 6, 2014
P2, N=397, Completed, Sponsor: Takeda
Not yet recruiting --> Recruiting Recruiting --> Completed
- | triptorelin / Generic mfg.
Enrollment change, Metastases: GREAT: GP Extended Action Triptorelin (clinicaltrials.gov) - Apr 28, 2014
P4, N=21, Completed, Sponsor: Ipsen
Recruiting --> Completed N=17 --> 21
- | triptorelin / Generic mfg.
Trial completion, Metastases: GREAT: GP Extended Action Triptorelin (clinicaltrials.gov) - Apr 28, 2014
P4, N=21, Completed, Sponsor: Ipsen
N=17 --> 21 Active, not recruiting --> Completed
- Climara (estradiol) / Bausch Health, Bayer
Clinical: Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women (clinicaltrials.gov) - Apr 22, 2014
P=N/A, N=34, Not yet recruiting, Sponsor: University of Colorado, Denver
- Xtandi (enzalutamide capsule) / Pfizer, Astellas
Trial initiation date, Combination therapy: Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer (clinicaltrials.gov) - Apr 21, 2014
P1, N=24, Recruiting, Sponsor: Thomas Jefferson University
Active, not recruiting --> Completed Initiation date: Jun 2014 --> Apr 2014
- Xtandi (enzalutamide capsule) / Pfizer, Astellas
Enrollment open, Combination therapy: Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer (clinicaltrials.gov) - Apr 21, 2014
P1, N=24, Recruiting, Sponsor: Thomas Jefferson University
Initiation date: Jun 2014 --> Apr 2014 Not yet recruiting --> Recruiting
- ||| Orgovyx (relugolix) / Intas, Gedeon Richter, Takeda, ASKA Pharma, Sumitomo Pharma, Pfizer
Trial initiation date: A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer (clinicaltrials.gov) - Apr 20, 2014
P2, N=125, Recruiting, Sponsor: Millennium Pharmaceuticals, Inc.
Not yet recruiting --> Recruiting Initiation date: Mar 2014 --> Apr 2014
- |||| Orgovyx (relugolix) / Intas, Gedeon Richter, Takeda, ASKA Pharma, Sumitomo Pharma, Pfizer
Enrollment open: A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer (clinicaltrials.gov) - Apr 20, 2014
P2, N=125, Recruiting, Sponsor: Millennium Pharmaceuticals, Inc.
Initiation date: Mar 2014 --> Apr 2014 Not yet recruiting --> Recruiting
- Xtandi (enzalutamide capsule) / Pfizer, Astellas
Enrollment open: Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM) (clinicaltrials.gov) - Apr 15, 2014
P2, N=38, Recruiting, Sponsor: Duke University
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- progesterone / Generic mfg., leuprorelin depot / Generic mfg., estradiol valerate / Generic mfg.
Clinical: The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes (clinicaltrials.gov) - Apr 13, 2014
P=N/A, N=100, Not yet recruiting, Sponsor: Zekai Tahir Burak Maternity and Teaching Hospital
- | stapuldencel-T (DCVAC/PCa) / Sotio
New P2 trial, Combination therapy, Metastases: ASN-002-IL: Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer (clinicaltrials.gov) - Apr 6, 2014
P2, N=63, Active, not recruiting, Sponsor: Sotio a.s.
- stapuldencel-T (DCVAC/PCa) / Sotio
Enrollment closed, Combination therapy, Metastases: ASN-002-IL: Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer (clinicaltrials.gov) - Apr 6, 2014
P2, N=63, Active, not recruiting, Sponsor: Sotio a.s.
Not yet recruiting --> Recruiting Not yet recruiting --> Active, not recruiting
- | Suprefact (buserelin acetate) / Sanofi
Enrollment closed: Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy (clinicaltrials.gov) - Mar 13, 2014
P3, N=400, Active, not recruiting, Sponsor: University of British Columbia
Not yet recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||||||||| leuprolide acetate for depot suspension / Generic mfg.
New P3 trial: A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer (clinicaltrials.gov) - Mar 10, 2014
P3, N=240, Recruiting, Sponsor: Takeda France
- ||||| Orgovyx (relugolix) / Intas, Gedeon Richter, Takeda, ASKA Pharma, Sumitomo Pharma, Pfizer
New P2 trial: A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer (clinicaltrials.gov) - Mar 9, 2014
P2, N=125, Recruiting, Sponsor: Millennium Pharmaceuticals, Inc.
- |||| Avastin (bevacizumab) / Roche
Enrollment open, Metastases: BOOSTER: Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer (clinicaltrials.gov) - Mar 4, 2014
P2, N=160, Recruiting, Sponsor: Japan Breast Cancer Research Group
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- |||| Orgovyx (relugolix) / Intas, Gedeon Richter, Takeda, ASKA Pharma, Sumitomo Pharma, Pfizer
Trial completion: Efficacy and Safety of TAK-385 in the Treatment of Endometriosis (clinicaltrials.gov) - Feb 23, 2014
P2, N=487, Completed, Sponsor: Takeda
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||||||| leuprolide acetate for depot suspension / Generic mfg.
Trial completion: Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer (clinicaltrials.gov) - Feb 22, 2014
P3, N=120, Completed, Sponsor: GP-Pharm
Recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Insulin Resistance and Testosterone in Women (clinicaltrials.gov) - Feb 22, 2014
P2, N=36, Completed, Sponsor: University of Pennsylvania
No longer recruiting --> Completed Recruiting --> Completed
- |||| leuprolide acetate for depot suspension / Generic mfg.
Trial completion: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study (clinicaltrials.gov) - Feb 22, 2014
P2, N=90, Completed, Sponsor: Voyager Pharmaceutical Corporation
Recruiting --> Completed No longer recruiting --> Completed
- |||| leuprolide acetate for depot suspension / Generic mfg.
Trial completion: ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (clinicaltrials.gov) - Feb 22, 2014
P2, N=90, Completed, Sponsor: Voyager Pharmaceutical Corporation
No longer recruiting --> Completed No longer recruiting --> Completed
- ||| Trial completion: Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=164, Completed, Sponsor: Abbott
No longer recruiting --> Completed No longer recruiting --> Completed
- Menopur (menotropin) / Ferring, Orgalutran (ganirelix acetate) / Organon, Follistim AQ Cartridge (follitropin beta) / Organon
New P4 trial: Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation (clinicaltrials.gov) - Feb 20, 2014
P4, N=50, Not yet recruiting, Sponsor: Michigan Reproductive Medicine
- | thalidomide / Generic mfg.
Trial completion: Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer (clinicaltrials.gov) - Feb 19, 2014
P3, N=159, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed No longer recruiting --> Completed
- | Emcyt (estramustine) / Pfizer, Nippon Shinyaku
Trial completion, Combination therapy, Metastases: Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=18, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- leuprolide acetate for depot suspension / Generic mfg., anastrozole / Generic mfg.
Trial initiation date: Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading (clinicaltrials.gov) - Feb 19, 2014
P0, N=250, Not yet recruiting, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Initiation date: Jan 2013 --> Jun 2014
- | Xtandi (enzalutamide capsule) / Pfizer, Astellas
New P2 trial: Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer (clinicaltrials.gov) - Feb 13, 2014
P2, N=15, Not yet recruiting, Sponsor: University of Texas Southwestern Medical Center
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment open: Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition (clinicaltrials.gov) - Feb 11, 2014
P=N/A, N=32, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Initiation date: Jan 2013 --> Jun 2014 Not yet recruiting --> Recruiting
- | Ibrance (palbociclib) / Pfizer
New P2 trial, Metastases: A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer (clinicaltrials.gov) - Feb 9, 2014
P2, N=60, Not yet recruiting, Sponsor: University of Michigan Cancer Center
- | Xtandi (enzalutamide capsule) / Pfizer, Astellas
New P2 trial, Metastases: LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer (clinicaltrials.gov) - Feb 6, 2014
P2, N=92, Not yet recruiting, Sponsor: Barbara Ann Karmanos Cancer Institute
- |||| Xtandi (enzalutamide capsule) / Pfizer, Astellas
Trial completion: Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer (clinicaltrials.gov) - Feb 6, 2014
P2, N=52, Completed, Sponsor: Medivation, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Xtandi (enzalutamide capsule) / Pfizer, Astellas
New P2 trial: Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM) (clinicaltrials.gov) - Feb 5, 2014
P2, N=38, Recruiting, Sponsor: Duke University
- | everolimus / Generic mfg.
Enrollment open: S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (clinicaltrials.gov) - Jan 29, 2014
P3, N=3500, Recruiting, Sponsor: Southwest Oncology Group
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | leuprolide acetate for depot suspension / Generic mfg.
Trial completion, Surgery: Medical Treatment of Endometriosis-Associated Pelvic Pain (clinicaltrials.gov) - Jan 22, 2014
P3, N=194, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting --> Recruiting Recruiting --> Completed
- goserelin acetate / Generic mfg., leuprolide acetate for depot suspension / Generic mfg.
Enrollment closed: Bipolar Androgen-based Therapy for Prostate Cancer (BAT) (clinicaltrials.gov) - Jan 12, 2014
P2, N=33, Active, not recruiting, Sponsor: Sidney Kimmel Comprehensive Cancer Center
Recruiting --> Completed Recruiting --> Active, not recruiting
- leuprolide acetate for depot suspension / Generic mfg., flutamide / Generic mfg.
Trial completion: Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer (clinicaltrials.gov) - Jan 1, 2014
P2, N=105, Completed, Sponsor: Herbert Irving Comprehensive Cancer Center
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Xtandi (enzalutamide capsule) / Pfizer, Astellas
New P1 trial, Combination therapy: Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer (clinicaltrials.gov) - Dec 26, 2013
P1, N=24, Recruiting, Sponsor: Thomas Jefferson University
- ||||| Avastin (bevacizumab) / Roche
New P2 trial, Metastases: BOOSTER: Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer (clinicaltrials.gov) - Nov 19, 2013
P2, N=160, Recruiting, Sponsor: Japan Breast Cancer Research Group
- Trial completion, Surgery, Biopsy: Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA (clinicaltrials.gov) - Nov 12, 2013
P2, N=2, Completed, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | tamoxifen / Generic mfg.
Trial completion: Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer (clinicaltrials.gov) - Oct 31, 2013
P3, N=1000, Completed, Sponsor: Scottish Cancer Therapy Network
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change, Surgery, Biopsy: Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA (clinicaltrials.gov) - Oct 10, 2013
P2, N=2, Completed, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Active, not recruiting --> Completed N=25 --> 2
- ||| leuprorelin depot / Generic mfg.
Clinical: CRONOS II: Evaluation of Diet and Exercise in Prostate Cancer Patients (clinicaltrials.gov) - Oct 9, 2013
P=N/A, N=860, Recruiting, Sponsor: AbbVie
- goserelin acetate / Generic mfg., leuprolide acetate for depot suspension / Generic mfg.
Trial completion: Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer (clinicaltrials.gov) - Sep 24, 2013
P2, N=63, Completed, Sponsor: Cancer and Leukemia Group B
N=25 --> 2 Active, not recruiting --> Completed
- | Yervoy (ipilimumab) / BMS
Enrollment closed: Ipilimumab + Androgen Depravation Therapy in Prostate Cancer (clinicaltrials.gov) - Sep 9, 2013
P2, N=48, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- GVAX prostate cancer vaccine / Novartis
Trial withdrawal, Metastases: Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer (clinicaltrials.gov) - Aug 15, 2013
P2, N=0, Withdrawn, Sponsor: Eastern Cooperative Oncology Group
Recruiting --> Active, not recruiting Not yet recruiting --> Withdrawn
- GVAX prostate cancer vaccine / Novartis
Enrollment change, Metastases: Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer (clinicaltrials.gov) - Aug 15, 2013
P2, N=0, Withdrawn, Sponsor: Eastern Cooperative Oncology Group
Not yet recruiting --> Withdrawn N=126 --> 0
- || leuprolide acetate for depot suspension / Generic mfg.
Enrollment closed: Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study (clinicaltrials.gov) - Aug 12, 2013
P=N/A, N=550, Active, not recruiting, Sponsor: AbbVie (prior sponsor, Abbott)
N=126 --> 0 Recruiting --> Active, not recruiting
- | Menopur (menotropin) / Ferring, Follistim AQ Cartridge (follitropin beta) / Organon, Bravelle (urofollitropin) / Ferring
New P4 trial: Maximal Stimulation and Delayed Fertilization for Diminished Ovarian Reserve: a Randomized Pilot Study (clinicaltrials.gov) - Aug 11, 2013
P4, N=100, Completed, Sponsor: Carolinas Healthcare System